CAPhO 2024 Sponsored Symposium Pfizer Canada - The Pharmacist’s View: New Horizons in Multiple Myeloma Management

Author/Presenter
Liam Berrigan
Muhammad Raza
Nizar Abdel-Samad
Category
Conference Presentations
Year Created
2024
Details

This symposium aims to provide a comprehensive understanding of

  • The evolving landscape of multiple myeloma, with a specific focus on BCMA-targeted therapies treatment.
  • Their associated adverse events
  • The role of pharmacists in patient management

Learning Objectives:

  • Describe the mechanisms of action of bispecific antibodies (bsAbs) targeting B-cell maturation antigen (BCMA) in the treatment of relapsed and/or refractory multiple myeloma (RRMM)
  • Compare the outcomes of BCMA-targeted therapies with standard treatment modalities for multiple myeloma
  • Develop strategies for monitoring and multidisciplinary management of adverse events related to BCMA-targeted agents in clinical practice

Sponsored by Pfizer Canada